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1Chapter
Presurgical Evaluation of Epilepsy 
Surgery
Tak Lap Poon
Abstract
Drug-resistant epilepsy (DRE) is defined as failure of two adequate trials of 
appropriately chosen and administered antiepileptic drugs. Approximately about 
30% of epilepsy patients are drug resistant. Accountable reasons to treatment 
failure including failure to recognize epilepsy syndrome, poor drug compliance, 
lifestyle factors, etc. In modern era of medicine, DRE patient should be encour-
aged to have early referral to tertiary epilepsy centre for presurgical evaluation. 
Comprehensive neurophysiology, structural neuroimaging, and neuropsychological 
and psychiatric assessment are regarded as essential elements. Invasive electroen-
cephalography (EEG) monitoring in terms of subdural electrodes, depth electrodes, 
foramen ovale electrodes, and more advanced technique using stereoelectroen-
cephalography (SEEG) are strong armamentarium for epilepsy surgeon. Epilepsy 
surgery in terms of resection, disconnection, or neuro-modulation should be 
recommended after a multi-disciplinary agreement.
Keywords: epilepsy surgery, drug resistant epilepsy, presurgical evaluation, 
anatomo-electro-clinical hypothesis
1. Introduction
Drug-resistant epilepsy (DRE) is defined as failure of two adequate trials of 
appropriately chosen and administered antiepileptic drugs. Approximately about 
30% of epilepsy patients are drug resistant. Accountable reasons to treatment 
failure including failure to recognize epilepsy syndrome, poor drug compliance, 
lifestyle factors etc. In modern era of medicine, DRE patient should be encour-
aged to have early referral to tertiary epilepsy centre for presurgical evaluation. 
Comprehensive neurophysiology, structural neuroimaging, neuropsychological 
and psychiatric assessment are regarded as essential elements. Invasive elec-
troencephalography (EEG) monitoring in terms of subdural electrodes, depth 
electrodes, foramen ovale electrodes, and more advanced technique using stereo-
electroencephalography (SEEG) are strong armamentarium for epilepsy surgeon. 
Epilepsy surgery in terms of resection, disconnection or neuro-modulation should 
be recommended after a multi-disciplinary agreement.
2. Background and definition of drug-resistant epilepsy (DRE)
Patients with epilepsy whose seizures do not respond successfully to anti-epilep-
tic drug (AED) therapy are considered to have drug-resistant epilepsy (DRE). The 
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prior equivalent term included medically intractable epilepsy or pharma-resistant 
epilepsy. This group of patient have the greatest burden of epilepsy related disabili-
ties, and also added the significantly the healthcare resources expenses.
In 2010, a consensus proposal from task force of the International League 
Against Epilepsy (ILAE) commission on therapeutic strategies. A framework com-
prises two “hierarchical” levels is proposed for definition of drug-resistant epilepsy 
(DRE). Level 1 is categorization of outcome to a therapeutic intervention and level 
2 is core definition of DRE based on how many “informative” trials of antiepileptic 
drugs (AEDs) resulted in a “treatment failure” outcome. The definition of DRE 
usually requires failure of two adequate trials of appropriately chosen and adminis-
tered antiepileptic drugs (be it sequential monotherapy or combined polytherapy) 
[1]. It is also important to include the impact of seizure factors (frequency, severity, 
associated behavioural problem) on individual psychosocial wellbeing. Such impact 
will lead to the physicians’ decision on drug options and the urgency of considering 
non-medical therapies.
Other important areas in the clinical assessment of DRE include the following.
2.1 The epidemiology
The prevalence of epilepsy patients aged 15 years or over in Chinese communi-
ties has been estimated at about 3–5.7 per 1000 [2], and about 40,000 Hong Kong 
people could be expected to have active epilepsy. The cumulative probability of a 
second attack at 1, 2, and 3 years was 30, 37 and 42% respectively. DRE comprised 
about one third of all epilepsy patients. A more recent study in 2008 showed the 
crude prevalence of active epilepsy and seizure disorder were estimated to be 
3.94/1000. So the cases that should have under tertiary care for consideration of 
intensive work up will be around 1000 cases annually. There existed a treatment 
or referral gap of 20 years in the United States for this group of patient [3, 4]. It is 
foreseen that the local condition will be similar and an unmet need should call for 
more escalated awareness.
2.2 The pathogenesis
Prospective studies with chronic epilepsy patients suggested that 70–80% of 
patients retain their status as intractable versus in remission [5]. In other words, 
a minority, around 20% of initial intractable seizure cases will archive seizure 
freedom in long run and vice versa. Postulated mechanism leading to intractability 
includes glial proliferation and dendritic sprouting with synaptic recognition [6] in 
mesial temporal sclerosis. The concept of paroxysmal depolarization shift (PDS) is 
cellular events in which rapidly repetitive action potentials are not followed by the 
usual refractory period, thereby generating a prolonged membrane depolarization. 
Repetitive neuronal firing probably underlies the interictal and ictal unit and local 
field recording of high frequency oscillations (HFO).
Another compelling theory is the build-up of epileptic “neuronal network” 
(NN), via alternation in neuronal circuitry [7, 8]. A well-defined NN example is 
the limbic network with sequential propagation path via hippocampus, amygdala, 
lateral temporal neocortex and entorhinal cortex, medial thalamus and frontal 
inferior lobes. The interest on neuronal network analysis in epilepsy had gained 
strength with the use of high resolution recording techniques. Seizures start in a 
well-defined brain area and spread at great speed to connected brain area recruiting 
specific neuronal networks into typical oscillatory behaviour. Therefore, epilepsies 
should be considered as resulting from disturbed network interactions that implies 
“multi-targeted treatments” [9–13].
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2.3 Clinical course or trajectories and complications
In a recent study using incident cohort of drug resistant epilepsy, which adopt 
ILAE DRE criteria, there are different patterns of disease progression or trajec-
tories observed [14]. The 30% proportion of patient eventually suffered from 
DRE was again observed. A long delay from disease onset to failure of second 
AED was also found. This finding might give insights to the pathogenesis as 
mentioned earlier.
The mortality and morbidity of DRE, is in general, believed to be higher than 
that of seizure free patients or patient with good seizure control [15–17]. Even in 
those that suffered from infrequent seizure, their daily life and subjective well-
being are also jeopardized in various extents [18].
2.4 The classification
It is a common practice, among epileptologist, to subdivide the refractory 
epilepsy cases into temporal lobe epilepsy (TLE) and non-temporal lobe epilepsy 
(NTLE). The former also constitute two distinct groups, namely, mesial temporal 
lobe epilepsy (mTLE) and neocortical temporal lobe epilepsy (NeTLE), according 
to the clinical and radiological manifestations. Both mTLE and NTLE shared similar 
pathological substrates (Table 1) apart from the mesial temporal sclerosis only found 
in the former. The TLE patients usually present with complex partial seizures, with or 
without generalized seizure, depending on the neuronal network involved. Though 
a minority of these TLE will became seizure free after repeated drug trials [15], most 
of the patients will run a clinical course of refractory seizure attack, and indeed, they 
form the most well-known surgically remediable epilepsy syndrome [19].
For the non TLE cases, the clinical and radiological features are diverse and also 
depend on the underlying etiologies or pathological substrates. In general, the seizure 
semiology is less well defined and the MRI abnormalities are variable and they are chal-
lenging in the perspective of seizure focus localization. Usually concerted effort and 
multi modalities investigations (in phase 1 of presurgical evaluation) are required [20].
3. Approach to drug treatment failure
Before considering referral to tertiary centre for work up of DRE for surgical 
intervention, there are certain reasons of treatment failure that should be considered:
Pathological substrate Mesial TLE Neocortical TLE
Mesial temporal sclerosis Most common Not present
The others: present in both
Neoplastic High grade or low grade glioma
Developmental Focal cortical dysplasia
Infective Viral encephalitis
Vascular Cavernous angioma
Migrational disorder DNET, ganglioglioma
Trauma Encephalomalacia
Table 1. 
Temporal lobe epilepsy (TLE) pathology.
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1. Failure to recognize a generalized epilepsy syndromes e.g. West’s syndrome, 
Rasmussen’s syndrome, autosomal dominant nocturnal frontal lobe epilepsy 
(ADNLE), early myoclonic encephalopathy (EME) etc.
2. Inappropriate choice of first line anti-epileptic drug (e.g. carbamazepine) that 
will aggravate seizures.
3. Poor drug compliance and lifestyle factors contributing to seizure recurrence.
These factors are often quoted as “pseudo-resistance” [21–23].
3.1 Guideline
There has been a number of regional and international consensus and guidelines 
related to comprehensive management of epilepsy surgery. In Hong Kong, the first 
guideline, The Hong Kong Epilepsy Guideline 2009, was published by the Hong Kong 
Epilepsy Society with the aim as a general guideline for the medical practitioner 
[24]. The Guideline included the following aspects:
1. Diagnosis, review, and referral
2. Patient education
3. Following a first seizure
4. Investigations
5. Classification
6. Principles of management
7. Pharmacological or AED management
8. Management of drug-resistant epilepsy
9. Side-effects of AEDs
10. Presurgical evaluation of drug-resistant epilepsy
11. Other forms of treatment
12. Prolonged seizures in the community
13. Treatment of status epilepticus
14. Perioperative management of seizure
15. Older people with epilepsy
16. Children and young people with epilepsy
The guidelines had the updated version in 2017–2018 and the whole guideline 
was divided into four sections addressing the following aspects including use of 
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antiepileptic drugs, guideline on status epilepticus, drug resistant epilepsy, and 
woman and epilepsy [25].
3.2 Selection of eligible candidate
There is observation that the longer the delay between the onset of DRE and 
the surgery, the lower the chance of postoperative seizure freedom and improved 
psychosocial outcome [26]. So a timely referral is mandatory for quality care of such 
group of patients.
Anyhow, before recruiting the patient, the first step is to identify the appropriate 
candidate. Conceptually, the eligibility criteria will include the following:
1. Patient and patient’s family understand and accept the surgical treatment and 
the potential risk
2. The seizure is disabling despite adequate and appropriate drug trial
3. The available imaging and neurophysiological data should be consistent with 
the possibility of a surgical remediable epileptic syndrome.
3.3 Presurgical evaluation
The first objective is to identify the epileptogenic zone, EZ by various invasive 
and non-invasive modalities of investigations. The more sophisticated or invasive 
approach will also depend on the clarity of structural identifiable pathologies in 
neuroimaging and the link with the clinical semiology.
The second objective, after screening of the potential epileptogenic zone, is to 
develop strategies to safeguard the lesion can be safely resected with no significant 
physical or cognitive sequelae.
The ultimate goal in presurgical evaluation is to identify the concept of “Six 
cortical zones” (Figure 1).
From pragmatic point of view, detailed interview of patient and patient’s family 
and friends who can give detailed witness history and past background is mandatory. 
The interview should aim for recapitulating all relevant past history and probably 
risk factor or etiological factors. The latter will also give insights to prognosis of the 
epileptic disorder with respect to surgical treatment. A good example will be a case of 
post encephalitic epilepsy will render surgical intervention less successful [27].
There should be a multi-disciplinary team and the respective investigations 
should include neuroimaging, psychiatric, neuropsychological and electrophysi-
ological assessment. A tertiary level or above epilepsy centre should have the 
available epilepsy surgery presurgical investigations of in two different levels:
• Level 1 investigations are compulsory to all epilepsy patients for better local-
ization of epileptogenic zone by means of: (1) improvement of detection of 
structural lesion on MRI, (2) mapping the source of interictal epileptiform dis-
charges, (3) detection of focal interictal brain dysfunction, and (4) detection 
of ictal focal brain hyperperfusion, and for assessment of risk of postoperative 
deficits by means of: (1) determination of hemisphere dominant for language, 
(2) prediction of risk of postoperative memory decline, (3) reduction of risk of 
visual field deficit, and (4) reduction of risk of motor deficit.
• Level 2 investigations are indicated for possible epilepsy surgery candidates 
with no formal conclusion about the localization or extension of epileptogenic 
zone. They are generally referring to those invasive monitoring tools.
Epilepsy
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3.4 Neurophysiology
The neurophysiological evaluation includes interictal and ictal EEG sampling, 
which can be attained by non-invasive or invasive means in a long term recording 
manner.
The inter-ictal EEG will provide important hint to lateralization or localization 
of EZ. This is particularly true in cases of TLE solely unilateral anterior temporal 
spike is a strong predictor of post-operative seizure freedom [28]. Anyhow, it is 
not uncommon to have unilateral MTS with bitemporal interictal epileptiform 
discharges found [29]. Another interictal EEG pattern with good localizing value is 
short bursts of low-voltage, high frequency oscillations associated with focal corti-
cal dysplasia [30].
Conceptually, the video EEG recording will capture the habitual seizures and the 
ictal EEG discharge and the lateralization and localization of the ictal onset zone 
can be deduced from analysis of adequate number of captured events.
After combined analysis of ictal and interictal EEG data, the irritative and ictal 
onset zones can be estimated [31].
Invasive recording is indicated when there is a hypothesis of epileptogenic zone 
that is not fully supported by the non- invasive diagnostic modalities results. These 
difficult scenarios are especially found in the non-lesional cases [32, 33].
3.5 Structural neuroimaging
Magnetic resonance imaging (MRI) of brain constitutes the basic, yet the most 
important investigation of choice in presurgical evaluation. It is particularly true in 
some epileptic disorder like temporal lobe epilepsy, of which mesial temporal scle-
rosis is the pathological substrate, got its unique radiological-anatomical correlates:
Figure 1. 
Six cortical zones.
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The MRI features of hippocampal sclerosis include (1) hippocampal atrophy 
on T1, (2) increased signal on T2-weighted images or fluid-attenuated inversion 
recovery (FLAIR) sequences, and (3) decreased signal on inversion recovery 
sequences [34, 35].
The detection of these abnormalities should be carried out with optimized imag-
ing techniques, which include angulated coronal sections obtained perpendicular to 
the long axis of the hippocampal structures.
For the extratemporal substrates, MRI can also define hemimegalencephaly, 
schizencephaly, and focal subcortical heterotopia. Focal cortical dysplasia is the 
most common developmental pathology in children with extratemporal lobe sei-
zures, and there is an international classification to define the underlying histopa-
thology and foretell the outlook of surgical success [36].
3 T MRI system has better signal-to-noise ratio, spatial and tissue contrast resolu-
tion than a 1.5 T system. Studies have shown that for initially nonlesional cases scanned 
by 1.5 T system with standard MRI brain protocol, more than half had new findings 
after rescanned by 3 T MRI system with multichannel phased-array coils (Figure 2).
The recommended MRI epilepsy protocol includes:
1. Volume acquisition T1W sequence acquired in oblique coronal orientation, 
orthogonal to long axis of hippocampus, covers whole brain in 0.9–1 mm 
partition
Figure 2. 
Patient was regarded to be non-lesional epilepsy initially in 1.5 T MRI (a) and found to have cortical dysplasia 
in left temporal stem in 3 T MRI (b). Another epilepsy patient had very subtle lesion in right subependymal 
region in 1.5 T MRI (c) and confirmed to be subependymal heterotopia by 3 T MRI (d).
Epilepsy
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2. Oblique coronal T2WTSE an T2W FLAIR sequences, orientated perpendicular 
to long axis of hippocampus, 2–3 mm slice thickness
3. Axial T2W or T2W FLAIR sequence of 3 mm slice thickness of whole brain
Diffusion tensor imaging (DTI) and tractography can be used for fiber 
tracking and noninvasive structural network mapping and is an optional imag-
ing sequence to aid preoperative planning for surgical trajectory. Recent study 
reported identification of significant diffusion abnormalities of tract sections in 
ipsilateral dorsal fornix and contralateral parahippocampal white matter bundle 
in patients with poor postoperative seizure control. Though more studies are war-
ranted to make conclusion, these results may help in understanding the mecha-
nism of postoperative persistent seizure and may act as imaging prognosticator 
for operation outcome.
However, there are pathological substrates that go beyond the detection of MRI 
analysis. As a result, multi-modality imaging of the brain will come into play [37–39].
There are some functional neuroimaging modalities, namely PET, SPECT, fMRI 
and magnetoencephalography (MEG). Some of these scans can be co-registered 
with MRI to give more detailed structural-functional correlated imaging analysis. 
They will aid the localization of epileptogenic zone, and the sensitivity will largely 
depend on the epileptic syndrome. MEG helps to localize the epileptogenic zone 
and delineate the relationship between the suspected abnormality and the relevant 
regions in the brain. The placement of invasive electrodes can be guided by the 
MEG findings. A MEG-guided review of MRI may reveal subtle abnormalities and 
permit a precise surgical excision of the irritative zone. MEG is also indicated in 
patients with multiple intracerebral lesions, such as multiple cavernomas, in whom 
a sole epileptogenic lesion may be identified for lesionectomy [40–43].
With such information, the indication of further invasive studies will also be 
justified (Figure 3).
Figure 3. 
Algorithm of workup of refractory epilepsy.
9Presurgical Evaluation of Epilepsy Surgery
DOI: http://dx.doi.org/10.5772/intechopen.93602
3.6 Neuropsychological assessment
Conceptually, the principle of neuropsychological batteries of test lies on the 
functional neuroanatomy(Table 2). It is controversial to state the prediction of 
postoperative cognitive outcome should be based on the side that was to be resected 
or the side that would remain following surgery.
There is always a long debate between the usage of WADA test and fMRI in deter-
mination of language dominance. In majority of cases, fMRI can clearly lateralize the 
language localization. However, in cases having agitation or mental compromise, or 
there is bilateral activations in fMRI, WADA test should be considered as a definitive 
test (Figure 4). Anyhow, the lower the mental reserve and the higher the functional 
adequacy of the resected tissue will preclude the surgical feasibility [44, 45].
3.7 Psychiatric assessment
It is recommended that the presurgical evaluation should include a thorough 
psychiatric assessment [32]. There are several reasons:
1. The prevalence of psychiatric disorder is prevalent in epilepsy patients, and 
psychopathology is common in patients with TLE.
2. Appropriate assessment might help to anticipate acute anxiety, delusions, and 
the latter symptoms might be aggravated in some temporal epilepsy cases, in 
perioperative period
3. The life time history of psychiatric disorder was associated with worst post-
surgical seizure outcome, though the existence of stable psychiatric disorder 
does not preclude epilepsy surgery.
The areas of assessment should include four domains, namely, behavioural, 
psychiatric, self-esteem profile and quality of life.
3.8 Invasive EEG studies
In general, the indications to consider invasive EEG monitoring are as the 
followings:
1. To define precisely the epileptogenic zone when non-invasive data are not 
concordant
2. To conclude the divergence of non-invasive data in different regions
3. To map eloquent cortical and subcortical function for resective surgery planning
Cognitive function Remark
Temporal lobe Memory and language Left side represents verbal memory
Right side represents visual memory
Frontal lobe Executive and behavior
Posterior part Perception and higher sensory
Table 2. 
Functional neuroanatomy.
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Figure 5. 
Types of invasive EEG studies: (a) subdural strips and grids, (b) intracerebral depth electrodes, (c) 
insular depth electrodes insertion with neuro-navigation guidance, (d) foramen ovale electrodes, and (e) 
stereoelectroencephalography (SEEG).
Figure 4. 
Clinical photo showing the setup for WADA test.
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4. To further validate the epileptogenic zone or provide information of prog-
nostic value
5. To perform therapeutic treatment for active regions using thermocoagulation
Traditionally, modalities of invasive EEG monitoring include subdural elec-
trodes, intracerebral depth electrodes, epidural peg electrodes and foramen ovale 
electrodes. A comprehensive review on risks and benefits in using subdural and 
depth electrodes showed that the related complications include epidural or subdural 
haemorrhage, intracerebral haemorrhage or contusion, meningitis, oedema around 
electrode, cerebral oedema, increased intracranial pressure etc. The overall compli-
cation rate ranges from 0.4% to 6.6%.
Stereoelectroencephalography (SEEG) is getting its popularity to enable precise 
recordings from deep cortical areas in bilateral and multiple lobes without subject-
ing the patients to have bilateral large craniotomies. The key and most important 
concept in considering SEEG is to test individualized anatomo-electro-clinical 
hypothesis. Based on clinical history, semiology, preoperative imaging and vEEG 
data, the findings of SEEG help the clinicians to understand the spatial and tempo-
ral dynamics of seizure i.e. where it starts, when and when it spreads. Study from 
Italian group showed that SEEG is a useful and relatively safe tool to localize the 
epileptogenic zone with procedure-related morbidity 5.6%. Other centres incorpo-
rate the neuro-robotic system in performing SEEG and showed comparable results. 
In general, SEEG had equivalent efficiency in determination of epileptogenic 
zone with lower operative morbidities and complications including CSF leak and 
intracranial haemorrhage, and better tolerance to patients. Current application of 
EEG recordings is not only limited to scalp EEG and intracranial EEG with subdural 
electrodes and depth electrodes (Figure 5) [46–49].
4. Epilepsy surgery for drug resistance epilepsy
The decision of surgical intervention is usually made in a consensus agreement 
among the discipline which carry out the investigation in a multi-disciplinary 
patient management conference in each epilepsy surgery centre. Basically it is a 
rational estimation of the precision of the epileptogenic zone (thus the success rate 
of seizure cure) and the risk benefit analysis of the potential post-operative risk.
In general, the outcome will be more favorable for lesional epileptic syndrome 
with concordance of investigation results and neuropsychological proof of 
“absence” of important cognitive function within the resected areas. On the con-
trary, the lack of concordance, the presence of important function in the pathologi-
cal substrate will preclude the surgical feasibility. Besides the disease factor, there 
are also patient factors like seizure frequency, duration of illness, comorbidity that 
will govern the prognostication [50].
Conventionally, the operative outcome will be categorized in four classes accord-
ing to Engel’s classification [51] (Table 3).
Class I Free of disabling seizures
Class II Rare disabling seizures (“almost seizure-free”)
Class III Worthwhile improvement
Class IV No worthwhile improvement
Table 3. 
Engel’s classification.
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The rationale is to have complete resection of the epileptogenic zone. Broadly 
there are three types of epilepsy surgery
1. Curative, respective surgery in terms of resection surgery involves temporal 
lobe surgery and extratemporal lobe surgery. Among the different epileptic 
syndrome, the mesial temporal sclerosis usually has the most favorable seizure 
outcome: 70% of the patients have Engel’s Class I [52, 53].
2. Palliative surgery in terms of disconnection surgery includes corpus calloso-
tomy, hemispherectomy (anatomical/functional), hemispherotomy, multiple 
subpial transections. All these procedure are often performed in pediatric 
group of patients and they had been shown to have seizure reduction ranged 
from 40 to 50% [54].
3. Modulatory, in terms of deep brain stimulation (DBS), vague nerve stimulation 
(VNS), responsive neurostimulation (RNS) and gamma knife radiosurgery [55]
5. Long-term outcome after epilepsy surgery
Epilepsy surgery for temporal lobe epilepsy is usually recommended because 
of promising result. One study including 80 patients with temporal lobe epilepsy 
showed that the cumulative proportion of patients who were free of seizures impair-
ing awareness was 58% in the surgical group and 8% in the medical group [56]. The 
Early Randomized Surgical Epilepsy Trial (ERSET) included 38 patients with mesial 
temporal lobe epilepsy and showed that zero of 23 participants in the medical group 
and 11 of 15 in the surgical group were seizure free during year 2 of follow-up [57]. 
Another study including more than 3000 patients from Germany concluded that the 
number of non-lesional patients and the need for intracranial recordings increased, 
and more than 50% of evaluated patients did not undergo surgery [58].
6. Treatment consideration for non-lesional epilepsy
There is always difficulty in identification of the epileptogenic zone in non-
lesional neocortical epilepsy. Seizure free outcomes are about 55% for non-lesional 
temporal lobe epilepsy and 43% for non-lesional extratemporal lobe epilepsy 
patients. Concordance with two or more presurgical evaluations including interictal 
EEG, ictal EEG, FDG-PET, and ictal SPECT was significantly related to a seizure-free 
outcome. Another study showed that 38% of non-lesional epilepsy patients had an 
excellent outcome after resective epilepsy surgery after long-term intracranial EEG. 
In temporal lobe epilepsy with MRI negative and PET positive findings, surgery could 
achieve Class I surgical outcomes at postoperative 2 years in about 82% [59, 60].
7. Factors related to failure in epilepsy surgery
Failure of epilepsy surgery may be caused by wrong localization of the epilepto-
genic zone, very widespread epileptogenic zones and very limited resection of the 
suspected epileptogenic zone.
In patient after mesial temporal resection, seizure may arise from neocortical 
regions instead of from residual hippocampal structure. This may imply the exis-
tence of regional epileptogenicity. Hippocampus represents the area of cortex with 
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the lowest threshold for seizure generation and the surrounding neocortical tissue 
also exhibiting epileptogenicity then becomes the site of ictal onset. About 25% of 
patients with seizure relapse after mesial temporal sclerosis may have seizure onset 
in the contralateral temporal region.
Extensive reevaluation of these patients is suggested for consideration of reop-
eration if epileptogenic focus can be localized.
8. Recent advance in epilepsy surgery
Minimally invasive intracranial endovascular EEG monitoring by means 
of nanowire and catheter and stent-electrode recordings is evolving [61]. High 
frequency Oscillations (HFOs) are believed as a potential marker for detection of 
epileptogenicity and predictive factor for epilepsy surgery outcome. However, a 
meta-analysis was able to show the significant but small relation between removal 
of HFO-generating brain region and outcome [62–64].
9. Conclusion
The prerequisite of seizure origin in a well circumscribed area of brain and 
the precision of localization of such epileptogenic zone by epilepsy work up make 
modern epilepsy surgery a promising treatment modality for refractory epilepsy.
The pre-operative assessment, which include multiple disciplines, however, 
should be focused on two important conceptual facets
1. Data concordance: the individual seizure pattern is ascribed to the hypothetical 
brain lesions, as suggested by neurophysiological and radiological data.
2. Functional reserve: the brain pathological region, if being resected, will not 
leave patient with significant morbidities
The advent of wide range of diagnostic tests and available surgical techniques 
has widened the applicability of surgical treatment. The success rate of these 
surgical interventions range from 10 to 20% of seizure reduction to more than 70% 
seizure freedom, depend on the different scenario.
In conclusion, epilepsy surgery for drug resistance epilepsy involves close 
collaboration and teamwork by multi-disciplinary specialties. Epilepsy surgery 
could be performed in different epilepsy centres. Patients should be referred early 
in their refractory disease course to a higher level epilepsy center for evaluation of 
the complex surgical options. Public education and promotion on management of 
refractory epilepsy by surgical treatments should be encouraged and lead by our 
local professional bodies and health organizations.
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